BBWI · Bath & Body Works
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $24.54
Note written ·
Price against the kill line
12.8% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $24.54, on record since 11 November 2026. The shares are up 14.9% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $24.54, over the February 2026 high, which would show the shares leading the S&P 500; so would a 19 November 2026 Q3 report with net sales down less than 2.5% and a raised FY2026 free-cash-flow outlook.
Research onlyNot in the portfolio.
Catalyst
Key figures from the filings · Consumer Discretionary
Quarter to 1 August 2026, filed 26 August 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 1,514
- Revenue, change on a year (%)
- −2.3
- Gross margin (%)
- 45.7
- Operating margin (%)
- 14.3
- Free cash flow, four quarters ($M)
- 1,031
- Net cash, cash less debt ($M)
- −2,820
- Price to earnings (×)
- 5.5
- Enterprise value to sales (×)
- 1.0
All filed numbers
What Bath & Body Works reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 1,514 | −2.3 | 45.7 | 14.3 |
| first filed | 1,378 | −3.2 | 42.6 | 16.8 |
| first filed | 2,724 | −2.3 | 45.7 | 22.0 |
| first filed | 1,594 | −1.0 | 41.3 | 10.1 |
| first filed | 1,549 | +1.5 | 41.3 | 10.1 |
| first filed | 1,424 | +2.9 | 45.4 | 14.7 |
| Pre-tax income ($M) | 164 |
| Net income ($M) four quarters: 781 | 118 |
| Diluted shares, change on a year (%) against the quarter to 2 August 2025 | −4.3 |
| Operating cash flow ($M) | 1,273 |
| Capital spending ($M) | 242 |
| Free cash flow ($M) | 1,031 |
| Cash and short-term investments ($M) | 794 |
| Debt ($M) non-current long-term debt plus current debt | 3,614 |
| Net cash, cash less debt ($M) | −2,820 |
| Deferred revenue ($M) +13.4% on a year | 195 |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 154 |
| Inventory ($M) | 883 |
| Shareholders' equity ($M) | −1,056 |
| Market value ($M) | 4,313 |
| Enterprise value, market value plus net debt ($M) | 7,133 |
| Enterprise value to sales (×) | 1.0 |
| Enterprise value to operating income (×) | 5.9 |
| Price to earnings (×) | 5.5 |
| Price to book value (×) | Not meaningful |
| Free-cash-flow yield (%) | 23.9 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 8.7% of shares outstanding sold short, 2.2 days of average trading to cover, −14.8% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $14 |
| 12 monthsfrom | $1.0M | $14 |
The thesis
Bath & Body Works shares are more likely to lag the S&P 500 than lead it over the next three months. Analysts already expect third-quarter earnings above the company's own forecast, and the shares trade near the average analyst target. The Q3 FY2026 report on 19 November 2026 settles whether sales and the roughly $650 million free-cash-flow outlook hold.
The rating is Low because the price already reflects a beat. MarketBeat's consensus on 12 November 2026 calls for Q3 earnings per share (EPS) of about $0.12 on revenue of $1.55 billion. Management guided Q3 EPS to $0.05–$0.10 on 26 August 2026, so the consensus sits above the top of that range. The shares closed at $21.72 on 11 November 2026, close to MarketBeat's $22.20 average analyst target.
The company's only financial news since August is the 5 November 2026 confirmation of the report date and the 6 November 2026 dividend declaration. Neither changes the numbers management gave on 26 August 2026. A Q3 net-sales decline narrower than 2.5%, with the cash-flow outlook raised, would show that the shares can lead.
Bullish and bearish views on Bath & Body Works, Inc.
The bull case on Bath & Body Works, Inc. (BBWI), in brief: Q2 sales beat company guidance. The bear case: consensus sits above the guide.
Bull case
- Q2 sales beat company guidance. The 26 August 2026 earnings release reported Q2 net sales of $1,514 million, down 2.3%, against management's forecast of a 3%–5% decline. Q3 is guided to a 2.5%–5% decline, so a result at or above the top of that range would extend the pattern.
- Cash-flow outlook stands at $650 million. Management guided FY2026 free cash flow to approximately $650 million on 26 August 2026 and full-year net sales to a decline of 2.5%–4%. The company has issued no change since.
- Analysts raised targets in late October. Wells Fargo raised its target to $25 from $24 and kept an Overweight rating on 29 October 2026 (Benzinga). JPMorgan went to $24 from $21 on 30 October 2026, and BMO went to $24 from $20 on 3 November 2026 (StockAnalysis).
- Holiday programme is in market. The company opened its first "Feel Good" concept store in Charlotte, North Carolina, on 23 October 2026. It launched the "Season of Wonder" campaign with Zooey Deschanel on 26 October 2026 and a new "A Thousand Wishes" collection on 2 November 2026 (company news).
- Activist pressure adds a separate path. Reuters, citing Bloomberg, reported on 10 September 2026 that Barington Capital is pressing the company to explore a sale. The company said it regularly engages with investors and is committed to evaluating ways to enhance shareholder value.
Bear case
- Consensus sits above the guide. MarketBeat's 12 November 2026 consensus of about $0.12 Q3 EPS is above the $0.05–$0.10 range management gave on 26 August 2026. A result inside the company's own range would still read as a miss.
- Core stores keep contracting. The 26 August 2026 release reported U.S./Canada store sales of $1,131 million, down 5.4%, about three-quarters of Q2 net sales. A companywide Q3 decline beyond 5% would show store weakness outweighing other channels.
- Q2 earnings carried a one-off. The company attributed about $0.31 of Q2's $0.62 adjusted EPS to a one-time $80 million tariff refund (26 August 2026 release).
- Most analysts remain neutral. MarketBeat counted 4 Buy, 15 Hold and 1 Sell ratings on 12 November 2026. StockAnalysis lists Telsey's target at $22 on 5 October 2026 and Goldman Sachs's at $19 on 8 September 2026, both near or below the 11 November 2026 close.
- Activist stake is small. Reuters, citing LSEG data, put Barington's holding at about 0.78 million shares, or 0.38%, as of 30 June 2026. Company news through 11 November 2026 discloses no sale process.
- This report has moved the shares sharply. TIKR reported a fall of almost 25% on the prior-year Q3 earnings miss and turnaround plan. Finance leadership is also interim: Tom Javitch has been interim chief financial officer since 12 June 2026.
Price setup
The shares closed at $21.72 on 11 November 2026, 12.9% below the 52-week intraday high of $24.94 set on 17 February 2026. The 52-week closing low was $14.85 on 21 November 2025. The three-month price change is 17.8%, measured from an $18.63 close on 13 August 2026.
The shares sit above both the 50-day moving average of $19.11 and the 200-day moving average of $19.54, as of 11 November 2026. The advance peaked in early November: the shares closed at $23.54 on 4 November 2026, then $22.08 on 5 November 2026 and $21.36 on 6 November 2026. They have held between $21.36 and $21.76 in the four sessions through 11 November 2026, with no company result in that span.
The February high is the level the case turns on. A close back above it, ahead of or after the report, would mean buyers are paying for more than the guided cash flow. SEC Form 4 filings since mid-August show one open-market insider sale: director Sarah E. Nash sold one share at $20.57 on 16 October 2026. The 23 September 2026 Form 8-K disclosed a performance-stock-unit award to CEO Daniel Heaf tied to stock-price hurdles over four years.
Catalysts ahead
- 19 November 2026: Q3 FY2026 results, before the market opens, as confirmed by the company on 5 November 2026. Tests the guided 2.5%–5% net-sales decline, the $0.05–$0.10 EPS range against a roughly $0.12 consensus, and the approximately $650 million FY2026 free-cash-flow outlook.
- 4 December 2026: Payment of the $0.20 quarterly dividend declared on 6 November 2026. Shows the company maintaining its cash payout through the turnaround and into the holiday quarter.
What would change the view
A daily close above $24.54, over the February 2026 high, which would show the shares leading the S&P 500; so would a 19 November 2026 Q3 report with net sales down less than 2.5% and a raised FY2026 free-cash-flow outlook.
What it trades with
U.S./Canada stores produced $1,131 million of the $1,514 million in Q2 net sales (26 August 2026 release), so the shares carry direct exposure to North American store traffic and discretionary spending. The dated drivers since August are company-specific: the Q2 report, the Barington story and analyst target changes. The 19 November 2026 report should move the shares more than any market factor that day; a move smaller than the S&P 500's on that session would show that view is wrong. The $0.20 dividend goes ex on 20 November 2026, the day after the report, which slightly lowers the quoted price that session.
The evidence, claim by claim (8)
- Consensus expects Q3 EPS of about $0.12 and revenue of $1.55 billion; MarketBeat counts 4 Buy, 15 Hold and 1 Sell ratings with a $22.20 average target. MarketBeat earnings preview, 12 November 2026 · as of
- The company said it plans to report Q3 FY2026 results before the market opens on Thursday, 19 November 2026. Bath & Body Works release, 5 November 2026 · as of
- The company declared a regular quarterly dividend of $0.20 per share, payable 4 December 2026 to holders of record on 20 November 2026. Bath & Body Works release, 6 November 2026 · as of
- BMO raised its price target to $24 from $20 and StockAnalysis lists its rating at Hold. StockAnalysis analyst ratings page · as of
- Wells Fargo raised its price target to $25 from $24 and kept an Overweight rating. Benzinga, 29 October 2026 · as of
- Q2 FY2026 net sales were $1,514 million, down 2.3%; U.S./Canada store sales were $1,131 million, down 5.4%. 26 August 2026 Q2 FY2026 earnings release · as of
- Management guided Q3 FY2026 net sales down 2.5%–5%, Q3 EPS of $0.05–$0.10 and FY2026 free cash flow of approximately $650 million. 26 August 2026 Q2 FY2026 earnings release · as of
- Reuters, citing Bloomberg, reported Barington Capital took a stake of about 0.78 million shares (0.38%, per LSEG data as of 30 June 2026) and is pressing the company to explore a sale. Reuters, 10 September 2026 · as of
Sources
- Bath & Body Works (BBWI) Set to Post Quarterly Earnings on Thursday · marketbeat.com ·
- Bath & Body Works to Report Third Quarter Results on November 19, 2026 · bbwinc.com ·
- Bath & Body Works Declares Cash Dividend · bbwinc.com ·
- Bath & Body Works Reports Second Quarter Results Exceeding Guidance and Continued Progress on Transformation · globenewswire.com ·
- Bath & Body Works, Inc. - Form 8-K - FY2026 · sec.gov
- Bath & Body Works, Inc. (BBWI) · stockanalysis.com
- Bath and Body Works (BBWI) Stock Plunges Almost 25% On Q3 Earnings Miss and Turnaround Plan · tikr.com
Related · shared themes
CPRI
Capri Holdings
Capri Holdings' Michael Kors turnaround gives the shares a modest edge over the S&P 500 after the 30 October 2026 beat-and-raise, despite a…
CROX
Crocs
Crocs, Inc. is more likely to lead the S&P 500 over three months: a third-quarter beat and a third guidance raise lifted full-year adjusted…
CRSR
Corsair Gaming
Corsair Gaming's recovery case holds after it beat third-quarter guidance and raised its 2026 outlook on 5 November 2026; the…
EL
Estee Lauder Companies
Estée Lauder's turnaround now shows in sales as well as margins, with first-quarter organic sales up 6% and the fiscal 2027 outlook raised…
See also · stocks to watch